Search results
Ozempic Maker Novo Nordisk Reprimanded by UK Regulators for Payment Disclosure Failures
Benzinga via Yahoo Singapore Finance· 12 hours agoNovo Nordisk A/S (NYSE:NVO), the maker of the popular obesity drug Ozempic, has been reprimanded by...
Roche's New Immunotherapy Fails To Show Benefit Over Merck's Blockbuster Keytruda In Lung Cancer...
Benzinga via Yahoo Singapore Finance· 17 hours agoOn Thursday, Roche Holdings AG (OTC:RHHBY) said that the Phase 2/3 SKYSCRAPER-06 study of...
Novo Nordisk reprimanded in UK for failure to disclose payments to healthcare sector
Reuters via Yahoo Singapore Finance· 15 hours agoDanish drugmaker Novo Nordisk has been reprimanded by UK regulators for failing to disclose fees and...